Ivan King, VP Research and Development at VION PHARMACEUTICALS INC (VION), sold 45,166 shares at $1.09 ($49K) on 2009-09-09, disclosed to the SEC on 2009-09-10.
Open-market sale of $49k VION by VP Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.